USANA Health Sciences, Inc. (FRA:USJ)
Germany · Delayed Price · Currency is EUR 16.60
-0.10 (-0.60%)
At close: Nov 28, 2025
USANA Health Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 27, 2025 | Dec '24 Dec 28, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Jan '21 Jan 2, 2021 | 2016 - 2020 |
| 912.67 | 854.5 | 921.01 | 998.6 | 1,186 | 1,135 | Upgrade | |
Revenue Growth (YoY) | 5.88% | -7.22% | -7.77% | -15.83% | 4.57% | 6.95% | Upgrade |
Cost of Revenue | 190 | 161.21 | 176.69 | 193.89 | 217.9 | 209.11 | Upgrade |
Gross Profit | 722.67 | 693.29 | 744.32 | 804.71 | 968.57 | 925.53 | Upgrade |
Selling, General & Admin | 680.85 | 626.97 | 651.25 | 697.1 | 798.37 | 749.04 | Upgrade |
Operating Expenses | 680.85 | 626.97 | 651.25 | 697.1 | 798.37 | 749.04 | Upgrade |
Operating Income | 41.82 | 66.32 | 93.07 | 107.61 | 170.19 | 176.49 | Upgrade |
Interest Expense | -0.85 | -0.28 | -0.26 | -0.19 | -0.06 | -0.51 | Upgrade |
Interest & Investment Income | 4.66 | 11.32 | 9.64 | 3.79 | 2.52 | 2.54 | Upgrade |
Other Non Operating Income (Expenses) | 2.15 | -1.01 | 0.01 | -2.59 | -2.01 | -0.57 | Upgrade |
Pretax Income | 47.78 | 76.35 | 102.45 | 108.62 | 170.64 | 177.95 | Upgrade |
Income Tax Expense | 30.22 | 34.29 | 38.67 | 39.27 | 54.14 | 53.28 | Upgrade |
Earnings From Continuing Operations | 17.56 | 42.06 | 63.79 | 69.35 | 116.51 | 124.66 | Upgrade |
Minority Interest in Earnings | -0.57 | -0.03 | - | - | - | - | Upgrade |
Net Income | 16.99 | 42.03 | 63.79 | 69.35 | 116.51 | 124.66 | Upgrade |
Net Income to Common | 16.99 | 42.03 | 63.79 | 69.35 | 116.51 | 124.66 | Upgrade |
Net Income Growth | -68.74% | -34.11% | -8.02% | -40.48% | -6.54% | 24.01% | Upgrade |
Shares Outstanding (Basic) | 19 | 19 | 19 | 19 | 20 | 21 | Upgrade |
Shares Outstanding (Diluted) | 19 | 19 | 19 | 19 | 20 | 21 | Upgrade |
Shares Change (YoY) | -2.18% | -0.95% | 0.18% | -5.08% | -4.29% | -6.84% | Upgrade |
EPS (Basic) | 0.91 | 2.20 | 3.31 | 3.60 | 5.78 | 5.89 | Upgrade |
EPS (Diluted) | 0.90 | 2.19 | 3.30 | 3.59 | 5.73 | 5.86 | Upgrade |
EPS Growth | -68.25% | -33.64% | -8.08% | -37.35% | -2.22% | 32.88% | Upgrade |
Free Cash Flow | 18.69 | 50.92 | 56.15 | 93.5 | 108.46 | 145.31 | Upgrade |
Free Cash Flow Per Share | 0.99 | 2.66 | 2.90 | 4.84 | 5.33 | 6.84 | Upgrade |
Gross Margin | 79.18% | 81.13% | 80.81% | 80.58% | 81.64% | 81.57% | Upgrade |
Operating Margin | 4.58% | 7.76% | 10.11% | 10.78% | 14.34% | 15.55% | Upgrade |
Profit Margin | 1.86% | 4.92% | 6.93% | 6.94% | 9.82% | 10.99% | Upgrade |
Free Cash Flow Margin | 2.05% | 5.96% | 6.10% | 9.36% | 9.14% | 12.81% | Upgrade |
EBITDA | 69.82 | 80.86 | 105.77 | 121.01 | 183.23 | 190.24 | Upgrade |
EBITDA Margin | 7.65% | 9.46% | 11.48% | 12.12% | 15.44% | 16.77% | Upgrade |
D&A For EBITDA | 28 | 14.54 | 12.7 | 13.39 | 13.04 | 13.75 | Upgrade |
EBIT | 41.82 | 66.32 | 93.07 | 107.61 | 170.19 | 176.49 | Upgrade |
EBIT Margin | 4.58% | 7.76% | 10.11% | 10.78% | 14.34% | 15.55% | Upgrade |
Effective Tax Rate | 63.26% | 44.91% | 37.74% | 36.15% | 31.72% | 29.94% | Upgrade |
Advertising Expenses | - | 4.97 | 4.76 | 5.05 | 12.4 | 9.85 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.